您使用提示模式 关闭

THNR - Amplify Weight Loss Drug & Treatment ETF (USD) (US0321085328)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选 清除所有
 
(%)
US0321085328
THNR ISIN
交易所交易基金 (ETF)
基金类型
Amplify Investments
提供商
24,4 USD
每股资产净值 | 2026-06-05
2024-05-21
成立日期
1 每年的次数
股息的支付
CEOJLS
CFI
THNR
代码
Formed
Status
Equity
投资项目
Healthcare
部门
Global
地区分布
VettaFi Weight Loss Drug & Treatment Index
基准
0.59 %
总成本比率
Physical
复制方法
4,15 百万 USD
基金资产总量 | 2026-06-05
4,15 百万 USD
股票类资产 | 2026-06-05
否
UCITS

收益率 在 2026-06-05, NYSE Arca

  • YTD
    -5,51 %
  • 1M
    -4,12 %
  • 3M
    -9,46 %
  • 6M
    -3,18 %
  • 1Y
    12,17 %
  • 3Y
    -
  • 5Y
    -
  • 10Y
    -
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (THNR)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The Amplify Weight Loss Drug & Treatment ETF seeks to replicate as closely as possible the price and yield performance of the VettaFi Weight Loss Drug & Treatment Index by investing in a portfolio comprised primarily of global companies involved in the pharmaceutical manufacturing of GLP-1 agonist

THNR profile

The Amplify Weight Loss Drug & Treatment ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Amplify Investments fund’s base currency is USD and the share class was registered 21.05.2024 with unique ISIN - US0321085328. Main exchange is NYSE Arca and ticker symbol is THNR. The total expense ratio is 0.59%. The Amplify Weight Loss Drug & Treatment ETF (USD) pays dividends 1 time(s) per year.

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权